Overview

Cellular Therapy With Cord Blood Cells

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving umbilical cord blood along with standard stem cells after high-dose chemotherapy will improve the response to a stem cell transplant. The safety of this treatment will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Fludarabine
Fludarabine phosphate
Melphalan
Rituximab
Vidarabine